Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears split testimony on autologous and directed blood donation bill; consideration carried over
Summary
Lawmakers heard testimony for and against House Bill 135, which would authorize and clarify autologous and directed blood donations and allow reasonable fees. Blood‑service providers warned of safety and resource concerns; proponents cited patient choice and historical contamination. The committee postponed further action to a future meeting.
The Labor, Health & Social Services Committee heard testimony on House Bill 135 on Jan. 20, 2025. The bill, sponsored by Representative Guggenmoss, would authorize autologous (self) and directed (designated donor) blood donations, allow blood banks to charge reasonable fees, and set definitions and rule‑making authority for the practice.
Supporters said the bill protects patient choice and allows patients to receive blood from known donors when they or their physicians prefer that option. Gil Levy of Pureblood Registry and other witnesses described the measure as restoring an established patient option and urged the committee to ensure that hospitals and blood centers facilitate autologous and directed donations. “This initiative ... ensures that families like mine can access trusted blood donations from close friends, family, and community during…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
